Fundly.ai, a finance startup based in Mumbai, said that Accel led a $3 million seed investment round for the company. Multiply Ventures and other angel investors participated in the round as additional investors. The pharmaceutical supply chain startup that assists distributors and retailers also provides them with the financial tools they need to manage better cash flows and boost their margins. According to Fundly.ai CEO Amit Chawla, the firm wants to concentrate on expanding in its current markets, which are in southern and western India.

Fundly.ai was started by Chawla and Shreeram Ramanathan in 2021 and is now operational in nine Indian cities. Throughout 2018 and 2019, the pair worked for InCred. "With this new funding, we are excited to expand our reach and explore untapped markets, bringing our vision of a more effective and efficient pharmaceutical supply chain to an even larger demographic," added Chawla.

By disbursing money totaling Rs 140 crore ($17.1 million), the firm has served over 2,000 shops and more than 30 distributors in nine locations to date. According to Chawla, Tamil Nadu accounts for roughly 55% of the company's revenue, followed by Maharashtra (30–35%) and Andhra Pradesh (the remaining percentage). According to the announcement, Fundly.ai intends to expand into new regions, improve engagement with current clients, build technology, and work on additional product offers.

Fundly.ai promises to connect retailers, distributors, and other stakeholders with product developments using finance as an entrance point. Sarthak Singh, an investor in Accel, stated. "With their extensive lending experience, Amit and Shree bring a wealth of knowledge. They have been able to spot openings and weaknesses in the pharmaceutical supply chain by drawing on their experience, Singh continued.